These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 17307803)

  • 1. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
    Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
    Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
    Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
    Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population.
    Losi-Guembarovski R; Cólus IM; De Menezes RP; Poliseli F; Chaves VN; Kuasne H; Leichsenring A; Guembarovski AL; Oliveira BW; Ramos G; Cavalcanti TC; Mizuno LT; Cavalli IJ; Ribeiro EM
    Anticancer Res; 2008; 28(2A):1023-8. PubMed ID: 18507050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione S-transferase polymorphisms and oral cancer: a case-control study in Rio de Janeiro, Brazil.
    Hatagima A; Costa EC; Marques CF; Koifman RJ; Boffetta P; Koifman S
    Oral Oncol; 2008 Feb; 44(2):200-7. PubMed ID: 17418613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population.
    Soya SS; Vinod T; Reddy KS; Gopalakrishnan S; Adithan C
    Eur J Cancer; 2007 Dec; 43(18):2698-706. PubMed ID: 17707637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.
    Shukla D; Dinesh Kale A; Hallikerimath S; Vivekanandhan S; Venkatakanthaiah Y
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Sep; 156(3):253-9. PubMed ID: 22660220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
    Olshan AF; Weissler MC; Watson MA; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.
    Hung HC; Chuang J; Chien YC; Chern HD; Chiang CP; Kuo YS; Hildesheim A; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):901-5. PubMed ID: 9367063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
    Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer.
    Gattás GJ; de Carvalho MB; Siraque MS; Curioni OA; Kohler P; Eluf-Neto J; Wünsch-Filho V
    Head Neck; 2006 Sep; 28(9):819-26. PubMed ID: 16721740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjects.
    Drummond SN; Gomez RS; Motta Noronha JC; Pordeus IA; Barbosa AA; De Marco L
    Oral Oncol; 2005 May; 41(5):515-9. PubMed ID: 15878757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
    Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
    Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.